
Σταδιοποίηση σε Ca Προστάτη
Ca Προστάτη |
||||||
AJCC Stages |
||||||
Stages |
T |
N |
M |
PSA |
Gleason |
|
I |
T1a-c |
N0 |
M0 |
PSA < 10 |
Gleason ≤ 6 |
|
T2a |
N0 |
M0 |
PSA < 10 |
Gleason ≤ 6 |
||
T1-2a |
N0 |
M0 |
PSA X |
Gleason X |
||
IIA |
T1a-c |
N0 |
M0 |
PSA < 20 |
Gleason 7 |
|
T1a-c |
N0 |
M0 |
10 ≤ PSA < 20 |
Gleason ≤ 6 |
||
T2a |
N0 |
M0 |
PSA < 20 |
Gleason ≤ 7 |
||
T2b |
N0 |
M0 |
PSA < 20 |
Gleason ≤ 7 |
||
T2b |
N0 |
M0 |
PSA X |
Gleason X |
||
IIB |
T2c |
N0 |
M0 |
Any PSA |
Any Gleason |
|
T1-2 |
N0 |
M0 |
PSA ≥ 20 |
Any Gleason |
||
T1-2 |
N0 |
M0 |
Any PSA |
Gleason ≥ 8 |
||
III |
T3a-b |
N0 |
M0 |
Any PSA |
Any Gleason |
|
IV |
T4 |
N0 |
M0 |
Any PSA |
Any Gleason |
|
Any T |
N1 |
M0 |
Any PSA |
Any Gleason |
||
Any T |
Any N |
M1 |
Any PSA |
Any Gleason |
||
When either PSA or Gleason is not available, grouping should be determined by T stage &/or either PSA or Gleason as available. |
||||||
(T) Primary Tumor |
||||||
Clinical |
|
|||||
TX |
Primary tumor cannot be assessed |
|||||
T0 |
No evidence of primary tumor |
|||||
T1 |
Clinically inapparent tumor neither palpable nor visible by imaging |
|||||
T1a |
Tumor incidental histologic finding in ≤ 5% of tissue resected |
|||||
T1b |
Tumor incidental histologic finding in > 5% of tissue resected |
|||||
T1c |
Tumor identified by needle biopsy (e.g., because of elevated PSA) |
|||||
T2 |
Tumor confined within prostate¹ |
|||||
T2a |
Tumor involves ≤ 1/2 of 1 lobe |
|||||
T2b |
Tumor involves > 1/2 of 1 lobe but not both lobes |
|||||
T2c |
Tumor involves both lobes |
|||||
T3 |
Tumor extends through the prostate capsule² |
|||||
T3a |
Extracapsular extension (unilateral or bilateral) |
|||||
T3b |
Tumor invades seminal vesicle(s) |
|||||
T4 |
Tumor is fixed or invades adjacent structures other than seminal vesicles, such as external sphincter, rectum, bladder, levator muscles, &/or pelvic wall |
|||||
Pathologic3 |
|
|||||
pT2 |
Organ confined |
|||||
pT2a |
Unilateral, ≤ 1/2 of 1 side |
|||||
pT2b |
Unilateral, involving > 1/2 of 1 side but not both sides |
|||||
pT2c |
Bilateral disease |
|||||
pT3 |
Extraprostatic extension |
|||||
pT3a |
Extraprostatic extension or microscopic invasion of bladder neck⁴ |
|||||
pT3b |
Seminal vesicle invasion |
|||||
pT4 |
Invasion of rectum, levator muscles, &/or pelvic wall |
|||||
¹ Tumor found in 1 or both lobes by needle biopsy, but not palpable or reliably visible by imaging, is classified as T1c. |
||||||
(N) Regional Lymph Nodes |
||||||
Clinical |
|
|||||
NX |
Regional lymph nodes were not assessed |
|||||
N0 |
No regional lymph node metastasis |
|||||
N1 |
Metastasis in regional lymph node(s) |
|||||
Pathologic |
|
|||||
pNX |
Regional nodes not sampled |
|||||
pN0 |
No positive regional nodes |
|||||
pN1 |
Metastases in regional node(s) |
|||||
(M) Distant Metastasis |
||||||
M0 |
No distant metastasis |
|||||
M1 |
Distant metastasis |
|||||
M1a |
Nonregional lymph node(s) |
|||||
M1b |
Bone(s) |
|||||
M1c |
Other site(s) with or without bone disease |
|||||
When > 1 site of metastasis is present, the most advanced category is used (pM1c is most advanced). |
||||||
(G) Histologic Grade |
||||||
GX |
Gleason score cannot be processed |
|||||
Gleason ≤ 6 |
Well differentiated (slight anaplasia) |
|||||
Gleason 7 |
Moderately differentiated (moderate anaplasia) |
|||||
Gleason 8-10 |
Poorly differentiated/undifferentiated (marked anaplasia) |
|||||
Χαρακτηριστικά Επέκτασης |
||||||
|
||||||
Κατηγοριοποίηση (Ιστολογικοί Τύποι) |
||||||
|